Silvia Sanchez Ramon


Country: Spain


  1. request reprint
    Sanchez Ramon S, Pérez de Diego R, Dieli Crimi R, Subiza J. Extending the clinical horizons of mucosal bacterial vaccines: current evidence and future prospects. Curr Drug Targets. 2014;15:1132-43 pubmed
    ..We also provide an overview completing the landscape of the potential clinical uses of these active biological agents. ..
  2. Fernández Paredes L, de Diego R, de Andrés C, Sánchez Ramón S. Close Encounters of the First Kind: Innate Sensors and Multiple Sclerosis. Mol Neurobiol. 2017;54:101-114 pubmed publisher
    ..A better understanding of these interactions will provide important insights into the aetiopathogenesis of MS and could help design potential targets for novel therapies. ..
  3. Fernández Paredes L, Casrouge A, Decalf J, de Andrés C, Villar L, Pérez de Diego R, et al. Multimarker risk stratification approach at multiple sclerosis onset. Clin Immunol. 2017;181:43-50 pubmed publisher
  4. Palomares Ã, Sánchez Ramón S, Dávila I, Prieto L, Pérez de Llano L, Lleonart M, et al. dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies. Int J Mol Sci. 2017;18: pubmed publisher
    ..A better understanding of the multiple contributions of IgE to the inflammatory continuum of asthma could contribute to the development of novel therapeutic strategies for the disease. ..